R&D, strategic alliances and shareholder value in biotech industry.
The pharmaceutical and biotech firms widely engage in M&A and strategic alliance formation as alternative instruments for acquiring external resources in recent decades. This thesis aims to complement the existing accounting literature by analyzing how strategic alliance as a "soft" v...
Main Author: | |
---|---|
Other Authors: | |
Format: | Thesis |
Published: |
2008
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/7721 |
_version_ | 1811682531042394112 |
---|---|
author | Teng, Poi Leng. |
author2 | Tan, Patricia Mui Siang |
author_facet | Tan, Patricia Mui Siang Teng, Poi Leng. |
author_sort | Teng, Poi Leng. |
collection | NTU |
description | The pharmaceutical and biotech firms widely engage in M&A and strategic alliance formation as alternative instruments for acquiring external resources in recent
decades. This thesis aims to complement the existing accounting literature by analyzing how strategic alliance as a "soft" value driver is able to add value and create
shareholders' wealth by exploring the various roles of strategic alliances. This study hopes to provide a better understanding of strategic alliances and thus, help shape
proposals for improved information disclosure on organizational capital. |
first_indexed | 2024-10-01T03:58:19Z |
format | Thesis |
id | ntu-10356/7721 |
institution | Nanyang Technological University |
last_indexed | 2024-10-01T03:58:19Z |
publishDate | 2008 |
record_format | dspace |
spelling | ntu-10356/77212024-01-12T10:13:30Z R&D, strategic alliances and shareholder value in biotech industry. Teng, Poi Leng. Tan, Patricia Mui Siang Nanyang Business School DRNTU::Business::Industries and labor The pharmaceutical and biotech firms widely engage in M&A and strategic alliance formation as alternative instruments for acquiring external resources in recent decades. This thesis aims to complement the existing accounting literature by analyzing how strategic alliance as a "soft" value driver is able to add value and create shareholders' wealth by exploring the various roles of strategic alliances. This study hopes to provide a better understanding of strategic alliances and thus, help shape proposals for improved information disclosure on organizational capital. Master of Accountancy 2008-09-18T07:50:12Z 2008-09-18T07:50:12Z 2004 2004 Thesis http://hdl.handle.net/10356/7721 Nanyang Technological University application/pdf |
spellingShingle | DRNTU::Business::Industries and labor Teng, Poi Leng. R&D, strategic alliances and shareholder value in biotech industry. |
title | R&D, strategic alliances and shareholder value in biotech industry. |
title_full | R&D, strategic alliances and shareholder value in biotech industry. |
title_fullStr | R&D, strategic alliances and shareholder value in biotech industry. |
title_full_unstemmed | R&D, strategic alliances and shareholder value in biotech industry. |
title_short | R&D, strategic alliances and shareholder value in biotech industry. |
title_sort | r d strategic alliances and shareholder value in biotech industry |
topic | DRNTU::Business::Industries and labor |
url | http://hdl.handle.net/10356/7721 |
work_keys_str_mv | AT tengpoileng rdstrategicalliancesandshareholdervalueinbiotechindustry |